Report Content
Chapter 1 Methodology
1.1 Methodology
1.2 Market definitions
1.3 Forecast parameters
1.4 Data sources
1.4.1 Secondary
1.4.1.1 Paid sources
1.4.1.2 Unpaid sources
1.4.2 Primary
Chapter 2 Executive Summary
2.1 Prefilled syringes industry 3600 synopsis, 2016 – 2027
2.1.1 Business trends
2.1.2 Type trends
2.1.3 Design trends
2.1.4 Application trends
2.1.5 Regional trends
Chapter 3 Prefilled Syringes Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2016 – 2027
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing concerns regarding safety of injectables
3.3.1.2 Worldwide increase in incidences of diabetes and rheumatoid arthritis
3.3.1.3 Technological advancements in prefilled syringes in North America
3.3.1.4 Growing adoption of biosimilars in developed regions
3.3.2 Industry pitfalls and challenges
3.3.2.1 Complexities associated with prefilled syringes
3.4 Growth potential analysis
3.4.1 By type
3.4.2 By design
3.4.3 By application
3.5 Pricing analysis, 2020
3.6 Contribution of CMOs to prefilled syringes market, 2020
3.7 Trends in low volume prefilled syringes
3.8 Porter’s analysis
3.9 Competitive landscape, 2020
3.9.1 Company matrix analysis
3.10 PESTEL analysis
Chapter 4 Prefilled Syringes Market, By Type
4.1 Key segment trends
4.2 Glass
4.2.1 Market size, by region, 2016 – 2027
4.3 Plastic
4.3.1 Market size, by region, 2016 – 2027
Chapter 5 Prefilled Syringes Market, By Design
5.1 Key segment trends
5.2 Single chamber
5.2.1 Market size, by region, 2016 – 2027
5.3 Dual chamber
5.3.1 Market size, by region, 2016 – 2027
Chapter 6 Prefilled Syringes Market, By Application
6.1 Key segment trends
6.2 Diabetes
6.2.1 Market size, by region, 2016 – 2027
6.3 Rheumatoid arthritis
6.3.1 Market size, by region, 2016 – 2027
6.4 Anaphylaxis
6.4.1 Market size, by region, 2016 – 2027
6.5 Antithrombotic/thrombolytic therapy
6.5.1 Market size, by region, 2016 – 2027
6.6 Others
6.6.1 Market size, by region, 2016 – 2027
Chapter 7 Magnetic Beads Market, By Region
7.1 Key regional trends
7.2 Strategy dashboard, 2020
7.3 North America
7.3.1 Market size, by country 2016 – 2027
7.3.2 Market size, by type 2016 – 2027
7.3.3 Market size, by design, 2016 – 2027
7.3.4 Market size, by application, 2016 – 2027
7.3.5 U.S.
7.3.5.1 Market size, by type 2016 – 2027
7.3.5.2 Market size, by design, 2016 – 2027
7.3.5.3 Market size, by application, 2016 – 2027
7.3.6 Canada
7.3.6.1 Market size, by type 2016 – 2027
7.3.6.2 Market size, by design, 2016 – 2027
7.3.6.3 Market size, by application, 2016 – 2027
7.4 Europe
7.4.1 Market size, by country 2016 – 2027
7.4.2 Market size, by type 2016 – 2027
7.4.3 Market size, by design, 2016 – 2027
7.4.4 Market size, by application, 2016 – 2027
7.4.5 Germany
7.4.5.1 Market size, by type 2016 – 2027
7.4.5.2 Market size, by design, 2016 – 2027
7.4.5.3 Market size, by application, 2016 – 2027
7.4.6 UK
7.4.6.1 Market size, by type 2016 – 2027
7.4.6.2 Market size, by design, 2016 – 2027
7.4.6.3 Market size, by application, 2016 – 2027
7.4.7 France
7.4.7.1 Market size, by type 2016 – 2027
7.4.7.2 Market size, by design, 2016 – 2027
7.4.7.3 Market size, by application, 2016 – 2027
7.4.8 Spain
7.4.8.1 Market size, by type 2016 – 2027
7.4.8.2 Market size, by design, 2016 – 2027
7.4.8.3 Market size, by application, 2016 – 2027
7.4.9 Italy
7.4.9.1 Market size, by type 2016 – 2027
7.4.9.2 Market size, by design, 2016 – 2027
7.4.9.3 Market size, by application, 2016 – 2027
7.4.10 Russia
7.4.10.1 Market size, by type 2016 – 2027
7.4.10.2 Market size, by design, 2016 – 2027
7.4.10.3 Market size, by application, 2016 – 2027
7.5 Asia Pacific
7.5.1 Market size, by country 2016 – 2027
7.5.2 Market size, by type 2016 – 2027
7.5.3 Market size, by design, 2016 – 2027
7.5.4 Market size, by application, 2016 – 2027
7.5.5 Japan
7.5.5.1 Market size, by type 2016 – 2027
7.5.5.2 Market size, by design, 2016 – 2027
7.5.5.3 Market size, by application, 2016 – 2027
7.5.6 China
7.5.6.1 Market size, by type 2016 – 2027
7.5.6.2 Market size, by design, 2016 – 2027
7.5.6.3 Market size, by application, 2016 – 2027
7.5.7 India
7.5.7.1 Market size, by type 2016 – 2027
7.5.7.2 Market size, by design, 2016 – 2027
7.5.7.3 Market size, by application, 2016 – 2027
7.5.8 Australia
7.5.8.1 Market size, by type 2016 – 2027
7.5.8.2 Market size, by design, 2016 – 2027
7.5.8.3 Market size, by application, 2016 – 2027
7.5.9 South Korea
7.5.9.1 Market size, by type 2016 – 2027
7.5.9.2 Market size, by design, 2016 – 2027
7.5.9.3 Market size, by application, 2016 – 2027
7.6 Latin America
7.6.1 Market size, by country 2016 – 2027
7.6.2 Market size, by type 2016 – 2027
7.6.3 Market size, by design, 2016 – 2027
7.6.4 Market size, by application, 2016 – 2027
7.6.5 Brazil
7.6.5.1 Market size, by type 2016 – 2027
7.6.5.2 Market size, by design, 2016 – 2027
7.6.5.3 Market size, by application, 2016 – 2027
7.6.6 Mexico
7.6.6.1 Market size, by type 2016 – 2027
7.6.6.2 Market size, by design, 2016 – 2027
7.6.6.3 Market size, by application, 2016 – 2027
7.6.7 Argentina
7.6.7.1 Market size, by type 2016 – 2027
7.6.7.2 Market size, by design, 2016 – 2027
7.6.7.3 Market size, by application, 2016 – 2027
7.7 Middle East & Africa (MEA)
7.7.1 Market size, by country 2016 – 2027
7.7.2 Market size, by type 2016 – 2027
7.7.3 Market size, by design, 2016 – 2027
7.7.4 Market size, by application, 2016 – 2027
7.7.5 South Africa
7.7.5.1 Market size, by type 2016 – 2027
7.7.5.2 Market size, by design, 2016 – 2027
7.7.5.3 Market size, by application, 2016 – 2027
7.7.6 Saudi Arabia
7.7.6.1 Market size, by type 2016 – 2027
7.7.6.2 Market size, by design, 2016 – 2027
7.7.6.3 Market size, by application, 2016 – 2027
Chapter 8 Company Profiles
8.1 Baxter International Inc
8.1.1 Business overview
8.1.2 Financial data
8.1.3 Product landscape
8.1.4 Strategic Outlook
8.1.5 SWOT analysis
8.2 Becton Dickinson
8.2.1 Business overview
8.2.2 Financial Data
8.2.3 Product landscape
8.2.4 SWOT analysis
8.3 Catalent
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 Strategic Outlook
8.3.5 SWOT analysis
8.4 Debiotech S A
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Product landscape
8.4.4 SWOT analysis
8.5 Fresenius Kabi AG (Fresenius SE & Co KGaA)
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Product landscape
8.5.4 SWOT analysis
8.6 Gerresheimer
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 SWOT analysis
8.7 Nipro
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 Strategic Outlook
8.7.5 SWOT analysis
8.8 Schott
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Product landscape
8.8.4 Strategic Outlook
8.8.5 SWOT analysis
8.9 SHL Group
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Product landscape
8.9.4 SWOT analysis
8.10 Stevanato Group
8.10.1 Business overview
8.10.2 Financial data
8.10.3 Product landscape
8.10.4 Strategic Outlook
8.10.5 SWOT analysis
8.11 Terumo Europe NV
8.11.1 Business overview
8.11.2 Financial data
8.11.3 Product landscape
8.11.4 Strategic Outlook
8.11.5 SWOT analysis
8.12 West Pharmaceutical Services, Inc.
8.12.1 Business overview
8.12.2 Financial data
8.12.3 Product landscape
8.12.4 SWOT analysis
